Healio

Low-dose colchicine cost-effective in COLCOT trial, over lifetime

Please provide your email address to receive an email when new articles are posted on . A cost analysis of findings from the COLCOT trial showed that the addition of low-dose colchicine therapy to ...
TCTMD

Colchicine Cost-effective in Canada, and Even in the US: COLCOT

Low-dose colchicine not only lowers the risk of ischemic CV events post-MI, it also can do so cost-effectively, according to the latest numbers from COLCOT. This is true from the perspective of the ...
Healio

Review: Colchicine helpful in stable CAD, but long-term safety unknown

Please provide your email address to receive an email when new articles are posted on . In the research summary written on behalf of the LoDoCo2 Steering Committee, researchers said the self-assembly ...
TCTMD

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...
Business Insider

Colchicine significantly reduces the risk of first and total ischemic cardiovascular events by 23% and 34% respectively in addition to standard of care in patients with a ...

MONTREAL, Nov. 16, 2019 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) today announced results from the COLchicine Cardiovascular Outcomes Trial (COLCOT) which compared colchicine to placebo ...